Delayed-type hypersensitivity to heparin: diagnosis and therapeutic management

Annales de dermatologie et de vénéréologie
A NosbaumF Bérard

Abstract

Heparin is widely used as an anticoagulant and is indicated in the prevention and treatment of thromboembolic disorders. Heparin-induced delayed-type hypersensitivity presents as eczematous lesions, either at the injection site or generally, and affects 7.5% of patients on heparin. This poses diagnostic and therapeutic issues, since an alternative anticoagulant treatment is essential and the risk of cross-reactivity may be as high as 80%, depending on the type of heparin used. If delayed-type hypersensitivity is suspected, heparin-induced thrombocytopenia must first be ruled out, and heparin should be stopped. Fondaparinux is currently the first-line alternative, with a risk of cross-reactivity estimated at only 10%. The switch from a low-molecular-weight heparin (LMWH) to another LMWH is no longer recommended. The use of unfractionated heparin, danaparoid or hirudin may be warranted in the event of recurrence with fondaparinux, and an immuno-allergological work-up is needed to specify the exact profile of cross-allergies.

References

Nov 3, 2006·Thrombosis and Haemostasis·Ralf J LudwigWolf-Henning Boehncke
Jul 5, 2008·Journal of Cardiac Surgery·Shoban Dave, Miguel A Park
Oct 24, 2008·The British Journal of Dermatology·S LopezC Mayorga
Dec 5, 2008·The New England Journal of Medicine·David B BlossomRam Sasisekharan
Sep 30, 2009·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Marc SchindewolfRalf J Ludwig
Nov 6, 2009·Thrombosis and Haemostasis·Ram Sasisekharan, Zachary Shriver
Jan 9, 2010·Annals of the Royal College of Surgeons of England·Ewan BigsbyAlastair Whiteway
Jan 12, 2010·Annual Review of Medicine·Gowthami M Arepally, Thomas L Ortel
Feb 5, 2010·Journal of Thrombosis and Haemostasis : JTH·M SchindewolfE Lindhoff-Last

❮ Previous
Next ❯

Citations

Jan 28, 2014·Annales de dermatologie et de vénéréologie·C PhanA Soria

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Related Papers

CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
M SchindewolfR J Ludwig
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
Y BerkunM Shalit
Drug Safety : an International Journal of Medical Toxicology and Drug Experience
R WütschertH Bounameaux
© 2021 Meta ULC. All rights reserved